EX-1.1 OTHERDOC 2 0002.txt JOINT FILING AGREEMENTJoint Filing Agreement • November 21st, 2002 • Isaly Samuel D • Biological products, (no disgnostic substances)
The undersigned hereby agree that the Statement on this Schedule 13G/A, dated November 21, 2002, (the "Schedule 13G/A"), with respect to the Common Stock, par value $0.001 per share, of Discovery Laboratories, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G/A. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G/A, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
EX-1.1 OTHERDOC 2 0002.txt JOINT FILING AGREEMENT Exhibit 1.1 ---------- JOINT FILING AGREEMENTJoint Filing Agreement • October 14th, 2004 • Isaly Samuel D • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13G, dated October 8, 2004, (the "Schedule 13G"), with respect to the Common Stock, $0.01 par value per share, of Tanox Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • June 16th, 2004 • Isaly Samuel D • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13G, dated June 4, 2004, (the "Schedule 13G"), with respect to the Ordinary Shares, no par value per share, of Prana Biotechnology Limited is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • June 2nd, 2008 • Isaly Samuel D • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that the Statement on this Schedule 13D, dated June 2, 2008 (the “Schedule 13D”), with respect to the Common Stock, par value $.001 per share, of NxStage Medical, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • March 26th, 2012 • Isaly Samuel D • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13D, dated March 26, 2012 (the “Schedule 13D”), with respect to the common stock, $0.001 par value per share, of Anthera Pharmaceuticals, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • May 29th, 2008 • Isaly Samuel D • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13D, dated May 29, 2008 (the “Schedule 13D”), with respect to the Common Stock, par value $.001 per share, of Athersys, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • April 10th, 2008 • Isaly Samuel D • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on this Schedule 13D, dated April 10, 2008 (the “Schedule 13D”), with respect to the Common Stock, par value $.001 per share, of Insulet Corporation is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
